Antony Mersiades

Statistics

Publications

Citations

204

H-Index

Active since

2018

Affiliations

National Health and Medical Research Council(Current)

Chris O’Brien Lifehouse

The University of Sydney

Western NSW Local Health District

Royal North Shore Hospital

Antony Mersiades is an author at National Health and Medical Research Council specializing in pharmacotherapy, cannabis, and cannabinoid pharmacology.

ORCID

Top concepts

CannabisMedicinePharmacologyPharmacotherapyNeuropharmacologyCannabinoid Pharmacology

Publications per year

2018–2024

Publications

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Peter Grimison, Antony Mersiades, Adrienne Kirby et al. · Annals of Oncology · 2020 · 143 citations · Full text

Cannabis Use, Psychoactive Drug, Oral Thc +7

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

Antony Mersiades, Annette Tognela, Paul Haber et al. · BMJ Open · 2018 · 27 citations · Full text

Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial

Peter Grimison, Antony Mersiades, Adrienne Kirby et al. · Journal of Clinical Oncology · 2024 · 21 citations · Full text

A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

Lavinia Tan, Chris Brown, Antony Mersiades et al. · Nature Communications · 2024 · 13 citations · Full text

1–4 of 4